15.00 – 17.00 Speedinterviews Astra Zeneca (EN), Boehringer Ingelheim (EN), Janssen Cilag (EN), Novartis (EN) (CV-selectie)
Astra Zeneca | H4-16
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. In the Netherlands AstraZeneca is based in Zoetermeer.
“We push the boundaries of science to deliver life-changing medicines.”
Our purpose underpins everything we do. It gives us a reason to come to work every day. It reminds us why we exist as a company. It helps us deliver benefits to patients and create value for shareholders. It also sets the context for our employees’ activities and the roles of our teams, partners and other collaborators.
“We follow the science. We put patients first. We play to win. We do the right thing. We are entrepreneurial.”
Our values determine how we work together and the behaviours that are integral to our drive for success. Our values guide our decision making, define our beliefs and foster a strong AstraZeneca culture.
Boehringer Ingelheim | T3-10
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates presently with a total of some 50,000 employees worldwide.
The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects through, for example, the initiative “Making More Health” while also caring for employees. Respect, equal opportunity and reconciling career and family form the foundation of mutual cooperation. The company also focuses on environmental protection and sustainability in everything it does.
In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.
Janssen Cilag | H5-06
Who is Janssen? We’re more than 30,000 people working hard to prevent, treat, cure and stop some of the most devastating and complex diseases of our time. From heart disease to HIV, Alzheimer’s disease to cancer, we are committed to issues that touch everyone’s lives.
At Janssen, our employees start each day with a new opportunity to transform healthcare and improve the quality of life for people around the world.
We are looking at a future where the world of healthcare will be challenged by informed and empowered patients. We work for change that will improve access to medicines: the best available treatment at an affordable price. That’s why we at Janssen strive to provide access to effective and affordable medicines and related healthcare services to the people who need them.
We are always seeking talented people and leaders who can drive creativity, collaboration, and innovation at a successful, results-driven pharmaceutical company.
Novartis | J7-51
We believe Novartis is well prepared for a world with a growing, aging population and continuously evolving healthcare needs.
We believe innovation that produces breakthrough medicines and products will be more important than ever in the healthcare industry in the coming years. We maintain substantial investment in research and development (R&D) aimed at areas of unmet medical need.
Our product pipeline is fed by a distinctive research and clinical approach that focuses on scientific advances before market potential.
Our R&D strategy is to continue reinforcing therapeutic areas where we are already strong including oncology, cardiovascular, eye care, biosimilars and neuroscience and to expand into new disease areas that we believe are ripe for innovation, such as immuno-oncology, aging and regenerative medicine, and infectious diseases.